Ketamine has become the accessible face of psychedelic medicine. You can get it at a clinic in most major US cities, some insurance covers it, and your doctor might even recommend it. It's legal, administered by an anesthesiologist, and increasingly mainstream.
Ibogaine is the opposite of all that. It's Schedule I. You have to leave the country to access it legally. It requires cardiac screening and physician supervision. The experience lasts 18–36 hours.
Both get lumped under "psychedelic therapy." They're not the same thing. Here's the actual comparison.
How They Work — The Mechanism Difference
Ketamine is a dissociative anesthetic that primarily acts on the NMDA glutamate receptor. At sub-anesthetic doses, it produces antidepressant effects, often within hours. The effect is relatively short-lived — most patients do a series of infusions over 2–3 weeks, then maintenance sessions. Ketamine creates a temporary window of neuroplasticity during which therapeutic work can happen, but it doesn't appear to reset the underlying neurochemistry.
Ibogaine works on a broader range of receptors — opioid, serotonin, NMDA, and others. Its most studied effect is on the opioid receptor: ibogaine appears to reset the mu-opioid receptor in a way that dramatically reduces or eliminates physical withdrawal symptoms and post-acute craving in opioid-dependent patients. For PTSD, the proposed mechanism involves a waking processing of memory and emotional material that results in lasting shifts in how traumatic experiences are held.
The short version: ketamine is temporary and requires maintenance. Ibogaine is attempting a lasting change in one session.
What Each One Is Good For
| Condition | Ketamine | Ibogaine |
|---|---|---|
| Treatment-resistant depression | Strong evidence, FDA-approved (Spravato) | Not a primary indication |
| PTSD | Emerging evidence, some VA programs | Strong anecdotal + Stanford study data |
| Opioid use disorder | Not effective for withdrawal | Best-documented use case — interrupts withdrawal acutely |
| Alcohol use disorder | Some evidence (with therapy) | Anecdotal — less studied than opioids |
| General addiction reset | Indirect (via mood relief) | Direct neurological mechanism proposed |
The clearest distinction: if opioids are involved, ibogaine has no equivalent. Ketamine does not interrupt opioid withdrawal. It doesn't act on opioid receptors in the relevant way. For someone trying to get off fentanyl, heroin, or oxycodone, ketamine is not a substitute.
The Risk Comparison
Ketamine risks: At clinical doses, ketamine is well-tolerated. The main risks are blood pressure changes, dissociation, and psychological distress during the session. Long-term, there are concerns about bladder damage with heavy use and the potential for ketamine dependency itself. A good ketamine clinic manages these through monitoring and session limits.
Ibogaine risks: Ibogaine's most serious risk is cardiac. It prolongs the QT interval — an electrical property of the heart — which in rare cases can trigger fatal arrhythmia. This is why cardiac screening is non-negotiable before any legitimate ibogaine treatment. People with certain pre-existing cardiac conditions are screened out. Deaths have occurred at unsupervised sessions. At properly run clinics with physician oversight, the risk is manageable — but it is not trivial.
Cardiac screening is why you choose a clinic carefully. It is not a box to check. It’s the thing that keeps ibogaine safe.
Access and Cost
Ketamine: Legal in the US. Infusions run $400–$800 per session; a standard protocol is 6 sessions. Esketamine (Spravato) is FDA-approved and sometimes covered by insurance. Maintenance sessions are ongoing costs.
Ibogaine: Illegal in the US — must travel to Mexico. All-inclusive programs at reputable clinics run $5,000–$15,000 for 7–10 days, including medical supervision, screening, lodging, meals, and integration support. Typically a one-time treatment, not a maintenance protocol.
Which One Is Right for You?
If you're dealing with depression or anxiety and want a legal, accessible option with a solid evidence base, ketamine is worth exploring. It has more regulatory support and lower logistical barriers.
If you're dealing with opioid dependency, ibogaine is the only option in this category that addresses the neurochemistry directly. Ketamine won't help with withdrawal.
If you're a veteran with PTSD who has tried multiple treatments and wants the most aggressive reset available, ibogaine has the more dramatic reported outcomes — but also the more significant risk profile and logistical requirements.
Some people have done both in sequence: ibogaine for the acute addiction or trauma reset, ketamine for ongoing mood maintenance afterward. That's a conversation to have with a physician who understands both.
What we do at IbogaineAdvisor is help you figure out whether ibogaine specifically makes sense for your situation — and if it does, connect you with the right clinic. If it doesn't, we'll tell you that too.